Pharma & Healthcare
Global Anti-Inflammatory Analgesic and Antipyretic Drugs Market Research Report 2025
- Jan 21, 25
- ID: 808065
- Pages: 117
- Figures: 111
- Views: 4
The global market for Anti-Inflammatory Analgesic and Antipyretic Drugs was valued at US$ 2806 million in the year 2024 and is projected to reach a revised size of US$ 3152 million by 2031, growing at a CAGR of 1.7% during the forecast period.
Anti-Inflammatory Analgesic and Antipyretic Drug can make the body temperature of a febrile patient return to normal, but have no effect on normal body temperature. These drugs also have moderate analgesic effects, but not as strong as morphine and its synthetic substitutes. Commonly used antipyretic and analgesic drugs can be divided into salicylic acid, aniline and pyrazolone according to their chemical structure. Among them, except aniline drugs have anti-rheumatic effect, but also can treat rheumatism and rheumatoid arthritis.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Anti-Inflammatory Analgesic and Antipyretic Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Anti-Inflammatory Analgesic and Antipyretic Drugs.
The Anti-Inflammatory Analgesic and Antipyretic Drugs market size, estimations, and forecasts are provided in terms of sales volume (Tons) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Anti-Inflammatory Analgesic and Antipyretic Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Anti-Inflammatory Analgesic and Antipyretic Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Mallinckrodt Pharmaceuticals
IOL
Anqiu Lu'an Pharmaceutical
Novacyl
BASF
Anhui BBCA Pharmaceuticals
Hubei Biocause
Xinhua Pharm
Granules India Limited
Huagang Pharm
Hebei Jiheng Pharmaceutical
Zhejiang Kangle Pharmaceutical
Hebei Jingye Medical Technology
MSPF
Lu'an Pharmaceutical
Mallinckrodt
Farmson
Anhui Fubore
SKPL
Atabay
Huzhou Konch Pharmaceutical
Anhui Topsun
SOLARA
SI Group
Segment by Type
Paracetamol
Aspirin
Ibuprofen
Naproxen
Diclofenac
Oxaprozin
Dexibuprofen
Others
Segment by Application
Adults
Children
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Anti-Inflammatory Analgesic and Antipyretic Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Anti-Inflammatory Analgesic and Antipyretic Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Anti-Inflammatory Analgesic and Antipyretic Drug can make the body temperature of a febrile patient return to normal, but have no effect on normal body temperature. These drugs also have moderate analgesic effects, but not as strong as morphine and its synthetic substitutes. Commonly used antipyretic and analgesic drugs can be divided into salicylic acid, aniline and pyrazolone according to their chemical structure. Among them, except aniline drugs have anti-rheumatic effect, but also can treat rheumatism and rheumatoid arthritis.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Anti-Inflammatory Analgesic and Antipyretic Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Anti-Inflammatory Analgesic and Antipyretic Drugs.
The Anti-Inflammatory Analgesic and Antipyretic Drugs market size, estimations, and forecasts are provided in terms of sales volume (Tons) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Anti-Inflammatory Analgesic and Antipyretic Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Anti-Inflammatory Analgesic and Antipyretic Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Mallinckrodt Pharmaceuticals
IOL
Anqiu Lu'an Pharmaceutical
Novacyl
BASF
Anhui BBCA Pharmaceuticals
Hubei Biocause
Xinhua Pharm
Granules India Limited
Huagang Pharm
Hebei Jiheng Pharmaceutical
Zhejiang Kangle Pharmaceutical
Hebei Jingye Medical Technology
MSPF
Lu'an Pharmaceutical
Mallinckrodt
Farmson
Anhui Fubore
SKPL
Atabay
Huzhou Konch Pharmaceutical
Anhui Topsun
SOLARA
SI Group
Segment by Type
Paracetamol
Aspirin
Ibuprofen
Naproxen
Diclofenac
Oxaprozin
Dexibuprofen
Others
Segment by Application
Adults
Children
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Anti-Inflammatory Analgesic and Antipyretic Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Anti-Inflammatory Analgesic and Antipyretic Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
1 Anti-Inflammatory Analgesic and Antipyretic Drugs Market Overview
1.1 Product Definition
1.2 Anti-Inflammatory Analgesic and Antipyretic Drugs by Type
1.2.1 Global Anti-Inflammatory Analgesic and Antipyretic Drugs Market Value Comparison by Type (2024 VS 2031)
1.2.2 Paracetamol
1.2.3 Aspirin
1.2.4 Ibuprofen
1.2.5 Naproxen
1.2.6 Diclofenac
1.2.7 Oxaprozin
1.2.8 Dexibuprofen
1.2.9 Others
1.3 Anti-Inflammatory Analgesic and Antipyretic Drugs by Application
1.3.1 Global Anti-Inflammatory Analgesic and Antipyretic Drugs Market Value by Application (2024 VS 2031)
1.3.2 Adults
1.3.3 Children
1.4 Global Anti-Inflammatory Analgesic and Antipyretic Drugs Market Size Estimates and Forecasts
1.4.1 Global Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue 2020-2031
1.4.2 Global Anti-Inflammatory Analgesic and Antipyretic Drugs Sales 2020-2031
1.4.3 Global Anti-Inflammatory Analgesic and Antipyretic Drugs Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Anti-Inflammatory Analgesic and Antipyretic Drugs Market Competition by Manufacturers
2.1 Global Anti-Inflammatory Analgesic and Antipyretic Drugs Sales Market Share by Manufacturers (2020-2025)
2.2 Global Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Anti-Inflammatory Analgesic and Antipyretic Drugs Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Anti-Inflammatory Analgesic and Antipyretic Drugs, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Anti-Inflammatory Analgesic and Antipyretic Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Anti-Inflammatory Analgesic and Antipyretic Drugs, Product Type & Application
2.7 Global Key Manufacturers of Anti-Inflammatory Analgesic and Antipyretic Drugs, Date of Enter into This Industry
2.8 Global Anti-Inflammatory Analgesic and Antipyretic Drugs Market Competitive Situation and Trends
2.8.1 Global Anti-Inflammatory Analgesic and Antipyretic Drugs Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Anti-Inflammatory Analgesic and Antipyretic Drugs Players Market Share by Revenue
2.8.3 Global Anti-Inflammatory Analgesic and Antipyretic Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Anti-Inflammatory Analgesic and Antipyretic Drugs Market Scenario by Region
3.1 Global Anti-Inflammatory Analgesic and Antipyretic Drugs Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Anti-Inflammatory Analgesic and Antipyretic Drugs Sales by Region: 2020-2031
3.2.1 Global Anti-Inflammatory Analgesic and Antipyretic Drugs Sales by Region: 2020-2025
3.2.2 Global Anti-Inflammatory Analgesic and Antipyretic Drugs Sales by Region: 2026-2031
3.3 Global Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue by Region: 2020-2031
3.3.1 Global Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue by Region: 2020-2025
3.3.2 Global Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue by Region: 2026-2031
3.4 North America Anti-Inflammatory Analgesic and Antipyretic Drugs Market Facts & Figures by Country
3.4.1 North America Anti-Inflammatory Analgesic and Antipyretic Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Anti-Inflammatory Analgesic and Antipyretic Drugs Sales by Country (2020-2031)
3.4.3 North America Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Anti-Inflammatory Analgesic and Antipyretic Drugs Market Facts & Figures by Country
3.5.1 Europe Anti-Inflammatory Analgesic and Antipyretic Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Anti-Inflammatory Analgesic and Antipyretic Drugs Sales by Country (2020-2031)
3.5.3 Europe Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Anti-Inflammatory Analgesic and Antipyretic Drugs Market Facts & Figures by Region
3.6.1 Asia Pacific Anti-Inflammatory Analgesic and Antipyretic Drugs Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Anti-Inflammatory Analgesic and Antipyretic Drugs Sales by Region (2020-2031)
3.6.3 Asia Pacific Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Anti-Inflammatory Analgesic and Antipyretic Drugs Market Facts & Figures by Country
3.7.1 Latin America Anti-Inflammatory Analgesic and Antipyretic Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Anti-Inflammatory Analgesic and Antipyretic Drugs Sales by Country (2020-2031)
3.7.3 Latin America Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Anti-Inflammatory Analgesic and Antipyretic Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Anti-Inflammatory Analgesic and Antipyretic Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Anti-Inflammatory Analgesic and Antipyretic Drugs Sales by Country (2020-2031)
3.8.3 Middle East and Africa Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Anti-Inflammatory Analgesic and Antipyretic Drugs Sales by Type (2020-2031)
4.1.1 Global Anti-Inflammatory Analgesic and Antipyretic Drugs Sales by Type (2020-2025)
4.1.2 Global Anti-Inflammatory Analgesic and Antipyretic Drugs Sales by Type (2026-2031)
4.1.3 Global Anti-Inflammatory Analgesic and Antipyretic Drugs Sales Market Share by Type (2020-2031)
4.2 Global Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue by Type (2020-2031)
4.2.1 Global Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue by Type (2020-2025)
4.2.2 Global Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue by Type (2026-2031)
4.2.3 Global Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue Market Share by Type (2020-2031)
4.3 Global Anti-Inflammatory Analgesic and Antipyretic Drugs Price by Type (2020-2031)
5 Segment by Application
5.1 Global Anti-Inflammatory Analgesic and Antipyretic Drugs Sales by Application (2020-2031)
5.1.1 Global Anti-Inflammatory Analgesic and Antipyretic Drugs Sales by Application (2020-2025)
5.1.2 Global Anti-Inflammatory Analgesic and Antipyretic Drugs Sales by Application (2026-2031)
5.1.3 Global Anti-Inflammatory Analgesic and Antipyretic Drugs Sales Market Share by Application (2020-2031)
5.2 Global Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue by Application (2020-2031)
5.2.1 Global Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue by Application (2020-2025)
5.2.2 Global Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue by Application (2026-2031)
5.2.3 Global Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue Market Share by Application (2020-2031)
5.3 Global Anti-Inflammatory Analgesic and Antipyretic Drugs Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Mallinckrodt Pharmaceuticals
6.1.1 Mallinckrodt Pharmaceuticals Company Information
6.1.2 Mallinckrodt Pharmaceuticals Description and Business Overview
6.1.3 Mallinckrodt Pharmaceuticals Anti-Inflammatory Analgesic and Antipyretic Drugs Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Mallinckrodt Pharmaceuticals Anti-Inflammatory Analgesic and Antipyretic Drugs Product Portfolio
6.1.5 Mallinckrodt Pharmaceuticals Recent Developments/Updates
6.2 IOL
6.2.1 IOL Company Information
6.2.2 IOL Description and Business Overview
6.2.3 IOL Anti-Inflammatory Analgesic and Antipyretic Drugs Sales, Revenue and Gross Margin (2020-2025)
6.2.4 IOL Anti-Inflammatory Analgesic and Antipyretic Drugs Product Portfolio
6.2.5 IOL Recent Developments/Updates
6.3 Anqiu Lu'an Pharmaceutical
6.3.1 Anqiu Lu'an Pharmaceutical Company Information
6.3.2 Anqiu Lu'an Pharmaceutical Description and Business Overview
6.3.3 Anqiu Lu'an Pharmaceutical Anti-Inflammatory Analgesic and Antipyretic Drugs Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Anqiu Lu'an Pharmaceutical Anti-Inflammatory Analgesic and Antipyretic Drugs Product Portfolio
6.3.5 Anqiu Lu'an Pharmaceutical Recent Developments/Updates
6.4 Novacyl
6.4.1 Novacyl Company Information
6.4.2 Novacyl Description and Business Overview
6.4.3 Novacyl Anti-Inflammatory Analgesic and Antipyretic Drugs Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Novacyl Anti-Inflammatory Analgesic and Antipyretic Drugs Product Portfolio
6.4.5 Novacyl Recent Developments/Updates
6.5 BASF
6.5.1 BASF Company Information
6.5.2 BASF Description and Business Overview
6.5.3 BASF Anti-Inflammatory Analgesic and Antipyretic Drugs Sales, Revenue and Gross Margin (2020-2025)
6.5.4 BASF Anti-Inflammatory Analgesic and Antipyretic Drugs Product Portfolio
6.5.5 BASF Recent Developments/Updates
6.6 Anhui BBCA Pharmaceuticals
6.6.1 Anhui BBCA Pharmaceuticals Company Information
6.6.2 Anhui BBCA Pharmaceuticals Description and Business Overview
6.6.3 Anhui BBCA Pharmaceuticals Anti-Inflammatory Analgesic and Antipyretic Drugs Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Anhui BBCA Pharmaceuticals Anti-Inflammatory Analgesic and Antipyretic Drugs Product Portfolio
6.6.5 Anhui BBCA Pharmaceuticals Recent Developments/Updates
6.7 Hubei Biocause
6.7.1 Hubei Biocause Company Information
6.7.2 Hubei Biocause Description and Business Overview
6.7.3 Hubei Biocause Anti-Inflammatory Analgesic and Antipyretic Drugs Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Hubei Biocause Anti-Inflammatory Analgesic and Antipyretic Drugs Product Portfolio
6.7.5 Hubei Biocause Recent Developments/Updates
6.8 Xinhua Pharm
6.8.1 Xinhua Pharm Company Information
6.8.2 Xinhua Pharm Description and Business Overview
6.8.3 Xinhua Pharm Anti-Inflammatory Analgesic and Antipyretic Drugs Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Xinhua Pharm Anti-Inflammatory Analgesic and Antipyretic Drugs Product Portfolio
6.8.5 Xinhua Pharm Recent Developments/Updates
6.9 Granules India Limited
6.9.1 Granules India Limited Company Information
6.9.2 Granules India Limited Description and Business Overview
6.9.3 Granules India Limited Anti-Inflammatory Analgesic and Antipyretic Drugs Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Granules India Limited Anti-Inflammatory Analgesic and Antipyretic Drugs Product Portfolio
6.9.5 Granules India Limited Recent Developments/Updates
6.10 Huagang Pharm
6.10.1 Huagang Pharm Company Information
6.10.2 Huagang Pharm Description and Business Overview
6.10.3 Huagang Pharm Anti-Inflammatory Analgesic and Antipyretic Drugs Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Huagang Pharm Anti-Inflammatory Analgesic and Antipyretic Drugs Product Portfolio
6.10.5 Huagang Pharm Recent Developments/Updates
6.11 Hebei Jiheng Pharmaceutical
6.11.1 Hebei Jiheng Pharmaceutical Company Information
6.11.2 Hebei Jiheng Pharmaceutical Description and Business Overview
6.11.3 Hebei Jiheng Pharmaceutical Anti-Inflammatory Analgesic and Antipyretic Drugs Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Hebei Jiheng Pharmaceutical Anti-Inflammatory Analgesic and Antipyretic Drugs Product Portfolio
6.11.5 Hebei Jiheng Pharmaceutical Recent Developments/Updates
6.12 Zhejiang Kangle Pharmaceutical
6.12.1 Zhejiang Kangle Pharmaceutical Company Information
6.12.2 Zhejiang Kangle Pharmaceutical Description and Business Overview
6.12.3 Zhejiang Kangle Pharmaceutical Anti-Inflammatory Analgesic and Antipyretic Drugs Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Zhejiang Kangle Pharmaceutical Anti-Inflammatory Analgesic and Antipyretic Drugs Product Portfolio
6.12.5 Zhejiang Kangle Pharmaceutical Recent Developments/Updates
6.13 Hebei Jingye Medical Technology
6.13.1 Hebei Jingye Medical Technology Company Information
6.13.2 Hebei Jingye Medical Technology Description and Business Overview
6.13.3 Hebei Jingye Medical Technology Anti-Inflammatory Analgesic and Antipyretic Drugs Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Hebei Jingye Medical Technology Anti-Inflammatory Analgesic and Antipyretic Drugs Product Portfolio
6.13.5 Hebei Jingye Medical Technology Recent Developments/Updates
6.14 MSPF
6.14.1 MSPF Company Information
6.14.2 MSPF Description and Business Overview
6.14.3 MSPF Anti-Inflammatory Analgesic and Antipyretic Drugs Sales, Revenue and Gross Margin (2020-2025)
6.14.4 MSPF Anti-Inflammatory Analgesic and Antipyretic Drugs Product Portfolio
6.14.5 MSPF Recent Developments/Updates
6.15 Lu'an Pharmaceutical
6.15.1 Lu'an Pharmaceutical Company Information
6.15.2 Lu'an Pharmaceutical Description and Business Overview
6.15.3 Lu'an Pharmaceutical Anti-Inflammatory Analgesic and Antipyretic Drugs Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Lu'an Pharmaceutical Anti-Inflammatory Analgesic and Antipyretic Drugs Product Portfolio
6.15.5 Lu'an Pharmaceutical Recent Developments/Updates
6.16 Mallinckrodt
6.16.1 Mallinckrodt Company Information
6.16.2 Mallinckrodt Description and Business Overview
6.16.3 Mallinckrodt Anti-Inflammatory Analgesic and Antipyretic Drugs Sales, Revenue and Gross Margin (2020-2025)
6.16.4 Mallinckrodt Anti-Inflammatory Analgesic and Antipyretic Drugs Product Portfolio
6.16.5 Mallinckrodt Recent Developments/Updates
6.17 Farmson
6.17.1 Farmson Company Information
6.17.2 Farmson Description and Business Overview
6.17.3 Farmson Anti-Inflammatory Analgesic and Antipyretic Drugs Sales, Revenue and Gross Margin (2020-2025)
6.17.4 Farmson Anti-Inflammatory Analgesic and Antipyretic Drugs Product Portfolio
6.17.5 Farmson Recent Developments/Updates
6.18 Anhui Fubore
6.18.1 Anhui Fubore Company Information
6.18.2 Anhui Fubore Description and Business Overview
6.18.3 Anhui Fubore Anti-Inflammatory Analgesic and Antipyretic Drugs Sales, Revenue and Gross Margin (2020-2025)
6.18.4 Anhui Fubore Anti-Inflammatory Analgesic and Antipyretic Drugs Product Portfolio
6.18.5 Anhui Fubore Recent Developments/Updates
6.19 SKPL
6.19.1 SKPL Company Information
6.19.2 SKPL Description and Business Overview
6.19.3 SKPL Anti-Inflammatory Analgesic and Antipyretic Drugs Sales, Revenue and Gross Margin (2020-2025)
6.19.4 SKPL Anti-Inflammatory Analgesic and Antipyretic Drugs Product Portfolio
6.19.5 SKPL Recent Developments/Updates
6.20 Atabay
6.20.1 Atabay Company Information
6.20.2 Atabay Description and Business Overview
6.20.3 Atabay Anti-Inflammatory Analgesic and Antipyretic Drugs Sales, Revenue and Gross Margin (2020-2025)
6.20.4 Atabay Anti-Inflammatory Analgesic and Antipyretic Drugs Product Portfolio
6.20.5 Atabay Recent Developments/Updates
6.21 Huzhou Konch Pharmaceutical
6.21.1 Huzhou Konch Pharmaceutical Company Information
6.21.2 Huzhou Konch Pharmaceutical Description and Business Overview
6.21.3 Huzhou Konch Pharmaceutical Anti-Inflammatory Analgesic and Antipyretic Drugs Sales, Revenue and Gross Margin (2020-2025)
6.21.4 Huzhou Konch Pharmaceutical Anti-Inflammatory Analgesic and Antipyretic Drugs Product Portfolio
6.21.5 Huzhou Konch Pharmaceutical Recent Developments/Updates
6.22 Anhui Topsun
6.22.1 Anhui Topsun Company Information
6.22.2 Anhui Topsun Description and Business Overview
6.22.3 Anhui Topsun Anti-Inflammatory Analgesic and Antipyretic Drugs Sales, Revenue and Gross Margin (2020-2025)
6.22.4 Anhui Topsun Anti-Inflammatory Analgesic and Antipyretic Drugs Product Portfolio
6.22.5 Anhui Topsun Recent Developments/Updates
6.23 SOLARA
6.23.1 SOLARA Company Information
6.23.2 SOLARA Description and Business Overview
6.23.3 SOLARA Anti-Inflammatory Analgesic and Antipyretic Drugs Sales, Revenue and Gross Margin (2020-2025)
6.23.4 SOLARA Anti-Inflammatory Analgesic and Antipyretic Drugs Product Portfolio
6.23.5 SOLARA Recent Developments/Updates
6.24 SI Group
6.24.1 SI Group Company Information
6.24.2 SI Group Description and Business Overview
6.24.3 SI Group Anti-Inflammatory Analgesic and Antipyretic Drugs Sales, Revenue and Gross Margin (2020-2025)
6.24.4 SI Group Anti-Inflammatory Analgesic and Antipyretic Drugs Product Portfolio
6.24.5 SI Group Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Anti-Inflammatory Analgesic and Antipyretic Drugs Industry Chain Analysis
7.2 Anti-Inflammatory Analgesic and Antipyretic Drugs Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Anti-Inflammatory Analgesic and Antipyretic Drugs Production Mode & Process Analysis
7.4 Anti-Inflammatory Analgesic and Antipyretic Drugs Sales and Marketing
7.4.1 Anti-Inflammatory Analgesic and Antipyretic Drugs Sales Channels
7.4.2 Anti-Inflammatory Analgesic and Antipyretic Drugs Distributors
7.5 Anti-Inflammatory Analgesic and Antipyretic Drugs Customer Analysis
8 Anti-Inflammatory Analgesic and Antipyretic Drugs Market Dynamics
8.1 Anti-Inflammatory Analgesic and Antipyretic Drugs Industry Trends
8.2 Anti-Inflammatory Analgesic and Antipyretic Drugs Market Drivers
8.3 Anti-Inflammatory Analgesic and Antipyretic Drugs Market Challenges
8.4 Anti-Inflammatory Analgesic and Antipyretic Drugs Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
1.1 Product Definition
1.2 Anti-Inflammatory Analgesic and Antipyretic Drugs by Type
1.2.1 Global Anti-Inflammatory Analgesic and Antipyretic Drugs Market Value Comparison by Type (2024 VS 2031)
1.2.2 Paracetamol
1.2.3 Aspirin
1.2.4 Ibuprofen
1.2.5 Naproxen
1.2.6 Diclofenac
1.2.7 Oxaprozin
1.2.8 Dexibuprofen
1.2.9 Others
1.3 Anti-Inflammatory Analgesic and Antipyretic Drugs by Application
1.3.1 Global Anti-Inflammatory Analgesic and Antipyretic Drugs Market Value by Application (2024 VS 2031)
1.3.2 Adults
1.3.3 Children
1.4 Global Anti-Inflammatory Analgesic and Antipyretic Drugs Market Size Estimates and Forecasts
1.4.1 Global Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue 2020-2031
1.4.2 Global Anti-Inflammatory Analgesic and Antipyretic Drugs Sales 2020-2031
1.4.3 Global Anti-Inflammatory Analgesic and Antipyretic Drugs Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Anti-Inflammatory Analgesic and Antipyretic Drugs Market Competition by Manufacturers
2.1 Global Anti-Inflammatory Analgesic and Antipyretic Drugs Sales Market Share by Manufacturers (2020-2025)
2.2 Global Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Anti-Inflammatory Analgesic and Antipyretic Drugs Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Anti-Inflammatory Analgesic and Antipyretic Drugs, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Anti-Inflammatory Analgesic and Antipyretic Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Anti-Inflammatory Analgesic and Antipyretic Drugs, Product Type & Application
2.7 Global Key Manufacturers of Anti-Inflammatory Analgesic and Antipyretic Drugs, Date of Enter into This Industry
2.8 Global Anti-Inflammatory Analgesic and Antipyretic Drugs Market Competitive Situation and Trends
2.8.1 Global Anti-Inflammatory Analgesic and Antipyretic Drugs Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Anti-Inflammatory Analgesic and Antipyretic Drugs Players Market Share by Revenue
2.8.3 Global Anti-Inflammatory Analgesic and Antipyretic Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Anti-Inflammatory Analgesic and Antipyretic Drugs Market Scenario by Region
3.1 Global Anti-Inflammatory Analgesic and Antipyretic Drugs Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Anti-Inflammatory Analgesic and Antipyretic Drugs Sales by Region: 2020-2031
3.2.1 Global Anti-Inflammatory Analgesic and Antipyretic Drugs Sales by Region: 2020-2025
3.2.2 Global Anti-Inflammatory Analgesic and Antipyretic Drugs Sales by Region: 2026-2031
3.3 Global Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue by Region: 2020-2031
3.3.1 Global Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue by Region: 2020-2025
3.3.2 Global Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue by Region: 2026-2031
3.4 North America Anti-Inflammatory Analgesic and Antipyretic Drugs Market Facts & Figures by Country
3.4.1 North America Anti-Inflammatory Analgesic and Antipyretic Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Anti-Inflammatory Analgesic and Antipyretic Drugs Sales by Country (2020-2031)
3.4.3 North America Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Anti-Inflammatory Analgesic and Antipyretic Drugs Market Facts & Figures by Country
3.5.1 Europe Anti-Inflammatory Analgesic and Antipyretic Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Anti-Inflammatory Analgesic and Antipyretic Drugs Sales by Country (2020-2031)
3.5.3 Europe Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Anti-Inflammatory Analgesic and Antipyretic Drugs Market Facts & Figures by Region
3.6.1 Asia Pacific Anti-Inflammatory Analgesic and Antipyretic Drugs Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Anti-Inflammatory Analgesic and Antipyretic Drugs Sales by Region (2020-2031)
3.6.3 Asia Pacific Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Anti-Inflammatory Analgesic and Antipyretic Drugs Market Facts & Figures by Country
3.7.1 Latin America Anti-Inflammatory Analgesic and Antipyretic Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Anti-Inflammatory Analgesic and Antipyretic Drugs Sales by Country (2020-2031)
3.7.3 Latin America Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Anti-Inflammatory Analgesic and Antipyretic Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Anti-Inflammatory Analgesic and Antipyretic Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Anti-Inflammatory Analgesic and Antipyretic Drugs Sales by Country (2020-2031)
3.8.3 Middle East and Africa Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Anti-Inflammatory Analgesic and Antipyretic Drugs Sales by Type (2020-2031)
4.1.1 Global Anti-Inflammatory Analgesic and Antipyretic Drugs Sales by Type (2020-2025)
4.1.2 Global Anti-Inflammatory Analgesic and Antipyretic Drugs Sales by Type (2026-2031)
4.1.3 Global Anti-Inflammatory Analgesic and Antipyretic Drugs Sales Market Share by Type (2020-2031)
4.2 Global Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue by Type (2020-2031)
4.2.1 Global Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue by Type (2020-2025)
4.2.2 Global Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue by Type (2026-2031)
4.2.3 Global Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue Market Share by Type (2020-2031)
4.3 Global Anti-Inflammatory Analgesic and Antipyretic Drugs Price by Type (2020-2031)
5 Segment by Application
5.1 Global Anti-Inflammatory Analgesic and Antipyretic Drugs Sales by Application (2020-2031)
5.1.1 Global Anti-Inflammatory Analgesic and Antipyretic Drugs Sales by Application (2020-2025)
5.1.2 Global Anti-Inflammatory Analgesic and Antipyretic Drugs Sales by Application (2026-2031)
5.1.3 Global Anti-Inflammatory Analgesic and Antipyretic Drugs Sales Market Share by Application (2020-2031)
5.2 Global Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue by Application (2020-2031)
5.2.1 Global Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue by Application (2020-2025)
5.2.2 Global Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue by Application (2026-2031)
5.2.3 Global Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue Market Share by Application (2020-2031)
5.3 Global Anti-Inflammatory Analgesic and Antipyretic Drugs Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Mallinckrodt Pharmaceuticals
6.1.1 Mallinckrodt Pharmaceuticals Company Information
6.1.2 Mallinckrodt Pharmaceuticals Description and Business Overview
6.1.3 Mallinckrodt Pharmaceuticals Anti-Inflammatory Analgesic and Antipyretic Drugs Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Mallinckrodt Pharmaceuticals Anti-Inflammatory Analgesic and Antipyretic Drugs Product Portfolio
6.1.5 Mallinckrodt Pharmaceuticals Recent Developments/Updates
6.2 IOL
6.2.1 IOL Company Information
6.2.2 IOL Description and Business Overview
6.2.3 IOL Anti-Inflammatory Analgesic and Antipyretic Drugs Sales, Revenue and Gross Margin (2020-2025)
6.2.4 IOL Anti-Inflammatory Analgesic and Antipyretic Drugs Product Portfolio
6.2.5 IOL Recent Developments/Updates
6.3 Anqiu Lu'an Pharmaceutical
6.3.1 Anqiu Lu'an Pharmaceutical Company Information
6.3.2 Anqiu Lu'an Pharmaceutical Description and Business Overview
6.3.3 Anqiu Lu'an Pharmaceutical Anti-Inflammatory Analgesic and Antipyretic Drugs Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Anqiu Lu'an Pharmaceutical Anti-Inflammatory Analgesic and Antipyretic Drugs Product Portfolio
6.3.5 Anqiu Lu'an Pharmaceutical Recent Developments/Updates
6.4 Novacyl
6.4.1 Novacyl Company Information
6.4.2 Novacyl Description and Business Overview
6.4.3 Novacyl Anti-Inflammatory Analgesic and Antipyretic Drugs Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Novacyl Anti-Inflammatory Analgesic and Antipyretic Drugs Product Portfolio
6.4.5 Novacyl Recent Developments/Updates
6.5 BASF
6.5.1 BASF Company Information
6.5.2 BASF Description and Business Overview
6.5.3 BASF Anti-Inflammatory Analgesic and Antipyretic Drugs Sales, Revenue and Gross Margin (2020-2025)
6.5.4 BASF Anti-Inflammatory Analgesic and Antipyretic Drugs Product Portfolio
6.5.5 BASF Recent Developments/Updates
6.6 Anhui BBCA Pharmaceuticals
6.6.1 Anhui BBCA Pharmaceuticals Company Information
6.6.2 Anhui BBCA Pharmaceuticals Description and Business Overview
6.6.3 Anhui BBCA Pharmaceuticals Anti-Inflammatory Analgesic and Antipyretic Drugs Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Anhui BBCA Pharmaceuticals Anti-Inflammatory Analgesic and Antipyretic Drugs Product Portfolio
6.6.5 Anhui BBCA Pharmaceuticals Recent Developments/Updates
6.7 Hubei Biocause
6.7.1 Hubei Biocause Company Information
6.7.2 Hubei Biocause Description and Business Overview
6.7.3 Hubei Biocause Anti-Inflammatory Analgesic and Antipyretic Drugs Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Hubei Biocause Anti-Inflammatory Analgesic and Antipyretic Drugs Product Portfolio
6.7.5 Hubei Biocause Recent Developments/Updates
6.8 Xinhua Pharm
6.8.1 Xinhua Pharm Company Information
6.8.2 Xinhua Pharm Description and Business Overview
6.8.3 Xinhua Pharm Anti-Inflammatory Analgesic and Antipyretic Drugs Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Xinhua Pharm Anti-Inflammatory Analgesic and Antipyretic Drugs Product Portfolio
6.8.5 Xinhua Pharm Recent Developments/Updates
6.9 Granules India Limited
6.9.1 Granules India Limited Company Information
6.9.2 Granules India Limited Description and Business Overview
6.9.3 Granules India Limited Anti-Inflammatory Analgesic and Antipyretic Drugs Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Granules India Limited Anti-Inflammatory Analgesic and Antipyretic Drugs Product Portfolio
6.9.5 Granules India Limited Recent Developments/Updates
6.10 Huagang Pharm
6.10.1 Huagang Pharm Company Information
6.10.2 Huagang Pharm Description and Business Overview
6.10.3 Huagang Pharm Anti-Inflammatory Analgesic and Antipyretic Drugs Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Huagang Pharm Anti-Inflammatory Analgesic and Antipyretic Drugs Product Portfolio
6.10.5 Huagang Pharm Recent Developments/Updates
6.11 Hebei Jiheng Pharmaceutical
6.11.1 Hebei Jiheng Pharmaceutical Company Information
6.11.2 Hebei Jiheng Pharmaceutical Description and Business Overview
6.11.3 Hebei Jiheng Pharmaceutical Anti-Inflammatory Analgesic and Antipyretic Drugs Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Hebei Jiheng Pharmaceutical Anti-Inflammatory Analgesic and Antipyretic Drugs Product Portfolio
6.11.5 Hebei Jiheng Pharmaceutical Recent Developments/Updates
6.12 Zhejiang Kangle Pharmaceutical
6.12.1 Zhejiang Kangle Pharmaceutical Company Information
6.12.2 Zhejiang Kangle Pharmaceutical Description and Business Overview
6.12.3 Zhejiang Kangle Pharmaceutical Anti-Inflammatory Analgesic and Antipyretic Drugs Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Zhejiang Kangle Pharmaceutical Anti-Inflammatory Analgesic and Antipyretic Drugs Product Portfolio
6.12.5 Zhejiang Kangle Pharmaceutical Recent Developments/Updates
6.13 Hebei Jingye Medical Technology
6.13.1 Hebei Jingye Medical Technology Company Information
6.13.2 Hebei Jingye Medical Technology Description and Business Overview
6.13.3 Hebei Jingye Medical Technology Anti-Inflammatory Analgesic and Antipyretic Drugs Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Hebei Jingye Medical Technology Anti-Inflammatory Analgesic and Antipyretic Drugs Product Portfolio
6.13.5 Hebei Jingye Medical Technology Recent Developments/Updates
6.14 MSPF
6.14.1 MSPF Company Information
6.14.2 MSPF Description and Business Overview
6.14.3 MSPF Anti-Inflammatory Analgesic and Antipyretic Drugs Sales, Revenue and Gross Margin (2020-2025)
6.14.4 MSPF Anti-Inflammatory Analgesic and Antipyretic Drugs Product Portfolio
6.14.5 MSPF Recent Developments/Updates
6.15 Lu'an Pharmaceutical
6.15.1 Lu'an Pharmaceutical Company Information
6.15.2 Lu'an Pharmaceutical Description and Business Overview
6.15.3 Lu'an Pharmaceutical Anti-Inflammatory Analgesic and Antipyretic Drugs Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Lu'an Pharmaceutical Anti-Inflammatory Analgesic and Antipyretic Drugs Product Portfolio
6.15.5 Lu'an Pharmaceutical Recent Developments/Updates
6.16 Mallinckrodt
6.16.1 Mallinckrodt Company Information
6.16.2 Mallinckrodt Description and Business Overview
6.16.3 Mallinckrodt Anti-Inflammatory Analgesic and Antipyretic Drugs Sales, Revenue and Gross Margin (2020-2025)
6.16.4 Mallinckrodt Anti-Inflammatory Analgesic and Antipyretic Drugs Product Portfolio
6.16.5 Mallinckrodt Recent Developments/Updates
6.17 Farmson
6.17.1 Farmson Company Information
6.17.2 Farmson Description and Business Overview
6.17.3 Farmson Anti-Inflammatory Analgesic and Antipyretic Drugs Sales, Revenue and Gross Margin (2020-2025)
6.17.4 Farmson Anti-Inflammatory Analgesic and Antipyretic Drugs Product Portfolio
6.17.5 Farmson Recent Developments/Updates
6.18 Anhui Fubore
6.18.1 Anhui Fubore Company Information
6.18.2 Anhui Fubore Description and Business Overview
6.18.3 Anhui Fubore Anti-Inflammatory Analgesic and Antipyretic Drugs Sales, Revenue and Gross Margin (2020-2025)
6.18.4 Anhui Fubore Anti-Inflammatory Analgesic and Antipyretic Drugs Product Portfolio
6.18.5 Anhui Fubore Recent Developments/Updates
6.19 SKPL
6.19.1 SKPL Company Information
6.19.2 SKPL Description and Business Overview
6.19.3 SKPL Anti-Inflammatory Analgesic and Antipyretic Drugs Sales, Revenue and Gross Margin (2020-2025)
6.19.4 SKPL Anti-Inflammatory Analgesic and Antipyretic Drugs Product Portfolio
6.19.5 SKPL Recent Developments/Updates
6.20 Atabay
6.20.1 Atabay Company Information
6.20.2 Atabay Description and Business Overview
6.20.3 Atabay Anti-Inflammatory Analgesic and Antipyretic Drugs Sales, Revenue and Gross Margin (2020-2025)
6.20.4 Atabay Anti-Inflammatory Analgesic and Antipyretic Drugs Product Portfolio
6.20.5 Atabay Recent Developments/Updates
6.21 Huzhou Konch Pharmaceutical
6.21.1 Huzhou Konch Pharmaceutical Company Information
6.21.2 Huzhou Konch Pharmaceutical Description and Business Overview
6.21.3 Huzhou Konch Pharmaceutical Anti-Inflammatory Analgesic and Antipyretic Drugs Sales, Revenue and Gross Margin (2020-2025)
6.21.4 Huzhou Konch Pharmaceutical Anti-Inflammatory Analgesic and Antipyretic Drugs Product Portfolio
6.21.5 Huzhou Konch Pharmaceutical Recent Developments/Updates
6.22 Anhui Topsun
6.22.1 Anhui Topsun Company Information
6.22.2 Anhui Topsun Description and Business Overview
6.22.3 Anhui Topsun Anti-Inflammatory Analgesic and Antipyretic Drugs Sales, Revenue and Gross Margin (2020-2025)
6.22.4 Anhui Topsun Anti-Inflammatory Analgesic and Antipyretic Drugs Product Portfolio
6.22.5 Anhui Topsun Recent Developments/Updates
6.23 SOLARA
6.23.1 SOLARA Company Information
6.23.2 SOLARA Description and Business Overview
6.23.3 SOLARA Anti-Inflammatory Analgesic and Antipyretic Drugs Sales, Revenue and Gross Margin (2020-2025)
6.23.4 SOLARA Anti-Inflammatory Analgesic and Antipyretic Drugs Product Portfolio
6.23.5 SOLARA Recent Developments/Updates
6.24 SI Group
6.24.1 SI Group Company Information
6.24.2 SI Group Description and Business Overview
6.24.3 SI Group Anti-Inflammatory Analgesic and Antipyretic Drugs Sales, Revenue and Gross Margin (2020-2025)
6.24.4 SI Group Anti-Inflammatory Analgesic and Antipyretic Drugs Product Portfolio
6.24.5 SI Group Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Anti-Inflammatory Analgesic and Antipyretic Drugs Industry Chain Analysis
7.2 Anti-Inflammatory Analgesic and Antipyretic Drugs Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Anti-Inflammatory Analgesic and Antipyretic Drugs Production Mode & Process Analysis
7.4 Anti-Inflammatory Analgesic and Antipyretic Drugs Sales and Marketing
7.4.1 Anti-Inflammatory Analgesic and Antipyretic Drugs Sales Channels
7.4.2 Anti-Inflammatory Analgesic and Antipyretic Drugs Distributors
7.5 Anti-Inflammatory Analgesic and Antipyretic Drugs Customer Analysis
8 Anti-Inflammatory Analgesic and Antipyretic Drugs Market Dynamics
8.1 Anti-Inflammatory Analgesic and Antipyretic Drugs Industry Trends
8.2 Anti-Inflammatory Analgesic and Antipyretic Drugs Market Drivers
8.3 Anti-Inflammatory Analgesic and Antipyretic Drugs Market Challenges
8.4 Anti-Inflammatory Analgesic and Antipyretic Drugs Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Anti-Inflammatory Analgesic and Antipyretic Drugs Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Anti-Inflammatory Analgesic and Antipyretic Drugs Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Anti-Inflammatory Analgesic and Antipyretic Drugs Market Competitive Situation by Manufacturers in 2024
Table 4. Global Anti-Inflammatory Analgesic and Antipyretic Drugs Sales (Tons) of Key Manufacturers (2020-2025)
Table 5. Global Anti-Inflammatory Analgesic and Antipyretic Drugs Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Anti-Inflammatory Analgesic and Antipyretic Drugs Average Price (US$/Ton) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Anti-Inflammatory Analgesic and Antipyretic Drugs, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Anti-Inflammatory Analgesic and Antipyretic Drugs, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Anti-Inflammatory Analgesic and Antipyretic Drugs, Product Type & Application
Table 12. Global Key Manufacturers of Anti-Inflammatory Analgesic and Antipyretic Drugs, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Anti-Inflammatory Analgesic and Antipyretic Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-Inflammatory Analgesic and Antipyretic Drugs as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Anti-Inflammatory Analgesic and Antipyretic Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Anti-Inflammatory Analgesic and Antipyretic Drugs Sales by Region (2020-2025) & (Tons)
Table 18. Global Anti-Inflammatory Analgesic and Antipyretic Drugs Sales Market Share by Region (2020-2025)
Table 19. Global Anti-Inflammatory Analgesic and Antipyretic Drugs Sales by Region (2026-2031) & (Tons)
Table 20. Global Anti-Inflammatory Analgesic and Antipyretic Drugs Sales Market Share by Region (2026-2031)
Table 21. Global Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue Market Share by Region (2020-2025)
Table 23. Global Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue Market Share by Region (2026-2031)
Table 25. North America Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Anti-Inflammatory Analgesic and Antipyretic Drugs Sales by Country (2020-2025) & (Tons)
Table 27. North America Anti-Inflammatory Analgesic and Antipyretic Drugs Sales by Country (2026-2031) & (Tons)
Table 28. North America Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Anti-Inflammatory Analgesic and Antipyretic Drugs Sales by Country (2020-2025) & (Tons)
Table 32. Europe Anti-Inflammatory Analgesic and Antipyretic Drugs Sales by Country (2026-2031) & (Tons)
Table 33. Europe Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Anti-Inflammatory Analgesic and Antipyretic Drugs Sales by Region (2020-2025) & (Tons)
Table 37. Asia Pacific Anti-Inflammatory Analgesic and Antipyretic Drugs Sales by Region (2026-2031) & (Tons)
Table 38. Asia Pacific Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Anti-Inflammatory Analgesic and Antipyretic Drugs Sales by Country (2020-2025) & (Tons)
Table 42. Latin America Anti-Inflammatory Analgesic and Antipyretic Drugs Sales by Country (2026-2031) & (Tons)
Table 43. Latin America Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Anti-Inflammatory Analgesic and Antipyretic Drugs Sales by Country (2020-2025) & (Tons)
Table 47. Middle East and Africa Anti-Inflammatory Analgesic and Antipyretic Drugs Sales by Country (2026-2031) & (Tons)
Table 48. Middle East and Africa Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Anti-Inflammatory Analgesic and Antipyretic Drugs Sales (Tons) by Type (2020-2025)
Table 51. Global Anti-Inflammatory Analgesic and Antipyretic Drugs Sales (Tons) by Type (2026-2031)
Table 52. Global Anti-Inflammatory Analgesic and Antipyretic Drugs Sales Market Share by Type (2020-2025)
Table 53. Global Anti-Inflammatory Analgesic and Antipyretic Drugs Sales Market Share by Type (2026-2031)
Table 54. Global Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue Market Share by Type (2020-2025)
Table 57. Global Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue Market Share by Type (2026-2031)
Table 58. Global Anti-Inflammatory Analgesic and Antipyretic Drugs Price (US$/Ton) by Type (2020-2025)
Table 59. Global Anti-Inflammatory Analgesic and Antipyretic Drugs Price (US$/Ton) by Type (2026-2031)
Table 60. Global Anti-Inflammatory Analgesic and Antipyretic Drugs Sales (Tons) by Application (2020-2025)
Table 61. Global Anti-Inflammatory Analgesic and Antipyretic Drugs Sales (Tons) by Application (2026-2031)
Table 62. Global Anti-Inflammatory Analgesic and Antipyretic Drugs Sales Market Share by Application (2020-2025)
Table 63. Global Anti-Inflammatory Analgesic and Antipyretic Drugs Sales Market Share by Application (2026-2031)
Table 64. Global Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue Market Share by Application (2020-2025)
Table 67. Global Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue Market Share by Application (2026-2031)
Table 68. Global Anti-Inflammatory Analgesic and Antipyretic Drugs Price (US$/Ton) by Application (2020-2025)
Table 69. Global Anti-Inflammatory Analgesic and Antipyretic Drugs Price (US$/Ton) by Application (2026-2031)
Table 70. Mallinckrodt Pharmaceuticals Company Information
Table 71. Mallinckrodt Pharmaceuticals Description and Business Overview
Table 72. Mallinckrodt Pharmaceuticals Anti-Inflammatory Analgesic and Antipyretic Drugs Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 73. Mallinckrodt Pharmaceuticals Anti-Inflammatory Analgesic and Antipyretic Drugs Product
Table 74. Mallinckrodt Pharmaceuticals Recent Developments/Updates
Table 75. IOL Company Information
Table 76. IOL Description and Business Overview
Table 77. IOL Anti-Inflammatory Analgesic and Antipyretic Drugs Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 78. IOL Anti-Inflammatory Analgesic and Antipyretic Drugs Product
Table 79. IOL Recent Developments/Updates
Table 80. Anqiu Lu'an Pharmaceutical Company Information
Table 81. Anqiu Lu'an Pharmaceutical Description and Business Overview
Table 82. Anqiu Lu'an Pharmaceutical Anti-Inflammatory Analgesic and Antipyretic Drugs Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 83. Anqiu Lu'an Pharmaceutical Anti-Inflammatory Analgesic and Antipyretic Drugs Product
Table 84. Anqiu Lu'an Pharmaceutical Recent Developments/Updates
Table 85. Novacyl Company Information
Table 86. Novacyl Description and Business Overview
Table 87. Novacyl Anti-Inflammatory Analgesic and Antipyretic Drugs Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 88. Novacyl Anti-Inflammatory Analgesic and Antipyretic Drugs Product
Table 89. Novacyl Recent Developments/Updates
Table 90. BASF Company Information
Table 91. BASF Description and Business Overview
Table 92. BASF Anti-Inflammatory Analgesic and Antipyretic Drugs Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 93. BASF Anti-Inflammatory Analgesic and Antipyretic Drugs Product
Table 94. BASF Recent Developments/Updates
Table 95. Anhui BBCA Pharmaceuticals Company Information
Table 96. Anhui BBCA Pharmaceuticals Description and Business Overview
Table 97. Anhui BBCA Pharmaceuticals Anti-Inflammatory Analgesic and Antipyretic Drugs Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 98. Anhui BBCA Pharmaceuticals Anti-Inflammatory Analgesic and Antipyretic Drugs Product
Table 99. Anhui BBCA Pharmaceuticals Recent Developments/Updates
Table 100. Hubei Biocause Company Information
Table 101. Hubei Biocause Description and Business Overview
Table 102. Hubei Biocause Anti-Inflammatory Analgesic and Antipyretic Drugs Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 103. Hubei Biocause Anti-Inflammatory Analgesic and Antipyretic Drugs Product
Table 104. Hubei Biocause Recent Developments/Updates
Table 105. Xinhua Pharm Company Information
Table 106. Xinhua Pharm Description and Business Overview
Table 107. Xinhua Pharm Anti-Inflammatory Analgesic and Antipyretic Drugs Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 108. Xinhua Pharm Anti-Inflammatory Analgesic and Antipyretic Drugs Product
Table 109. Xinhua Pharm Recent Developments/Updates
Table 110. Granules India Limited Company Information
Table 111. Granules India Limited Description and Business Overview
Table 112. Granules India Limited Anti-Inflammatory Analgesic and Antipyretic Drugs Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 113. Granules India Limited Anti-Inflammatory Analgesic and Antipyretic Drugs Product
Table 114. Granules India Limited Recent Developments/Updates
Table 115. Huagang Pharm Company Information
Table 116. Huagang Pharm Description and Business Overview
Table 117. Huagang Pharm Anti-Inflammatory Analgesic and Antipyretic Drugs Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 118. Huagang Pharm Anti-Inflammatory Analgesic and Antipyretic Drugs Product
Table 119. Huagang Pharm Recent Developments/Updates
Table 120. Hebei Jiheng Pharmaceutical Company Information
Table 121. Hebei Jiheng Pharmaceutical Description and Business Overview
Table 122. Hebei Jiheng Pharmaceutical Anti-Inflammatory Analgesic and Antipyretic Drugs Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 123. Hebei Jiheng Pharmaceutical Anti-Inflammatory Analgesic and Antipyretic Drugs Product
Table 124. Hebei Jiheng Pharmaceutical Recent Developments/Updates
Table 125. Zhejiang Kangle Pharmaceutical Company Information
Table 126. Zhejiang Kangle Pharmaceutical Description and Business Overview
Table 127. Zhejiang Kangle Pharmaceutical Anti-Inflammatory Analgesic and Antipyretic Drugs Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 128. Zhejiang Kangle Pharmaceutical Anti-Inflammatory Analgesic and Antipyretic Drugs Product
Table 129. Zhejiang Kangle Pharmaceutical Recent Developments/Updates
Table 130. Hebei Jingye Medical Technology Company Information
Table 131. Hebei Jingye Medical Technology Description and Business Overview
Table 132. Hebei Jingye Medical Technology Anti-Inflammatory Analgesic and Antipyretic Drugs Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 133. Hebei Jingye Medical Technology Anti-Inflammatory Analgesic and Antipyretic Drugs Product
Table 134. Hebei Jingye Medical Technology Recent Developments/Updates
Table 135. MSPF Company Information
Table 136. MSPF Description and Business Overview
Table 137. MSPF Anti-Inflammatory Analgesic and Antipyretic Drugs Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 138. MSPF Anti-Inflammatory Analgesic and Antipyretic Drugs Product
Table 139. MSPF Recent Developments/Updates
Table 140. Lu'an Pharmaceutical Company Information
Table 141. Lu'an Pharmaceutical Description and Business Overview
Table 142. Lu'an Pharmaceutical Anti-Inflammatory Analgesic and Antipyretic Drugs Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 143. Lu'an Pharmaceutical Anti-Inflammatory Analgesic and Antipyretic Drugs Product
Table 144. Lu'an Pharmaceutical Recent Developments/Updates
Table 145. Mallinckrodt Company Information
Table 146. Mallinckrodt Description and Business Overview
Table 147. Mallinckrodt Anti-Inflammatory Analgesic and Antipyretic Drugs Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 148. Mallinckrodt Anti-Inflammatory Analgesic and Antipyretic Drugs Product
Table 149. Mallinckrodt Recent Developments/Updates
Table 150. Farmson Company Information
Table 151. Farmson Description and Business Overview
Table 152. Farmson Anti-Inflammatory Analgesic and Antipyretic Drugs Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 153. Farmson Anti-Inflammatory Analgesic and Antipyretic Drugs Product
Table 154. Farmson Recent Developments/Updates
Table 155. Anhui Fubore Company Information
Table 156. Anhui Fubore Description and Business Overview
Table 157. Anhui Fubore Anti-Inflammatory Analgesic and Antipyretic Drugs Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 158. Anhui Fubore Anti-Inflammatory Analgesic and Antipyretic Drugs Product
Table 159. Anhui Fubore Recent Developments/Updates
Table 160. SKPL Company Information
Table 161. SKPL Description and Business Overview
Table 162. SKPL Anti-Inflammatory Analgesic and Antipyretic Drugs Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 163. SKPL Anti-Inflammatory Analgesic and Antipyretic Drugs Product
Table 164. SKPL Recent Developments/Updates
Table 165. Atabay Company Information
Table 166. Atabay Description and Business Overview
Table 167. Atabay Anti-Inflammatory Analgesic and Antipyretic Drugs Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 168. Atabay Anti-Inflammatory Analgesic and Antipyretic Drugs Product
Table 169. Atabay Recent Developments/Updates
Table 170. Huzhou Konch Pharmaceutical Company Information
Table 171. Huzhou Konch Pharmaceutical Description and Business Overview
Table 172. Huzhou Konch Pharmaceutical Anti-Inflammatory Analgesic and Antipyretic Drugs Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 173. Huzhou Konch Pharmaceutical Anti-Inflammatory Analgesic and Antipyretic Drugs Product
Table 174. Huzhou Konch Pharmaceutical Recent Developments/Updates
Table 175. Anhui Topsun Company Information
Table 176. Anhui Topsun Description and Business Overview
Table 177. Anhui Topsun Anti-Inflammatory Analgesic and Antipyretic Drugs Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 178. Anhui Topsun Anti-Inflammatory Analgesic and Antipyretic Drugs Product
Table 179. Anhui Topsun Recent Developments/Updates
Table 180. SOLARA Company Information
Table 181. SOLARA Description and Business Overview
Table 182. SOLARA Anti-Inflammatory Analgesic and Antipyretic Drugs Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 183. SOLARA Anti-Inflammatory Analgesic and Antipyretic Drugs Product
Table 184. SOLARA Recent Developments/Updates
Table 185. SI Group Company Information
Table 186. SI Group Description and Business Overview
Table 187. SI Group Anti-Inflammatory Analgesic and Antipyretic Drugs Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 188. SI Group Anti-Inflammatory Analgesic and Antipyretic Drugs Product
Table 189. SI Group Recent Developments/Updates
Table 190. Key Raw Materials Lists
Table 191. Raw Materials Key Suppliers Lists
Table 192. Anti-Inflammatory Analgesic and Antipyretic Drugs Distributors List
Table 193. Anti-Inflammatory Analgesic and Antipyretic Drugs Customers List
Table 194. Anti-Inflammatory Analgesic and Antipyretic Drugs Market Trends
Table 195. Anti-Inflammatory Analgesic and Antipyretic Drugs Market Drivers
Table 196. Anti-Inflammatory Analgesic and Antipyretic Drugs Market Challenges
Table 197. Anti-Inflammatory Analgesic and Antipyretic Drugs Market Restraints
Table 198. Research Programs/Design for This Report
Table 199. Key Data Information from Secondary Sources
Table 200. Key Data Information from Primary Sources
Table 201. Authors List of This Report
List of Figures
Figure 1. Product Picture of Anti-Inflammatory Analgesic and Antipyretic Drugs
Figure 2. Global Anti-Inflammatory Analgesic and Antipyretic Drugs Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Anti-Inflammatory Analgesic and Antipyretic Drugs Market Share by Type: 2024 & 2031
Figure 4. Paracetamol Product Picture
Figure 5. Aspirin Product Picture
Figure 6. Ibuprofen Product Picture
Figure 7. Naproxen Product Picture
Figure 8. Diclofenac Product Picture
Figure 9. Oxaprozin Product Picture
Figure 10. Dexibuprofen Product Picture
Figure 11. Others Product Picture
Figure 12. Global Anti-Inflammatory Analgesic and Antipyretic Drugs Market Value by Application (2020-2031) & (US$ Million)
Figure 13. Global Anti-Inflammatory Analgesic and Antipyretic Drugs Market Share by Application: 2024 & 2031
Figure 14. Adults
Figure 15. Children
Figure 16. Global Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 17. Global Anti-Inflammatory Analgesic and Antipyretic Drugs Market Size (2020-2031) & (US$ Million)
Figure 18. Global Anti-Inflammatory Analgesic and Antipyretic Drugs Sales (2020-2031) & (Tons)
Figure 19. Global Anti-Inflammatory Analgesic and Antipyretic Drugs Average Price (US$/Ton) & (2020-2031)
Figure 20. Anti-Inflammatory Analgesic and Antipyretic Drugs Report Years Considered
Figure 21. Anti-Inflammatory Analgesic and Antipyretic Drugs Sales Share by Manufacturers in 2024
Figure 22. Global Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue Share by Manufacturers in 2024
Figure 23. Global 5 and 10 Largest Anti-Inflammatory Analgesic and Antipyretic Drugs Players: Market Share by Revenue in Anti-Inflammatory Analgesic and Antipyretic Drugs in 2024
Figure 24. Anti-Inflammatory Analgesic and Antipyretic Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 25. Global Anti-Inflammatory Analgesic and Antipyretic Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 26. North America Anti-Inflammatory Analgesic and Antipyretic Drugs Sales Market Share by Country (2020-2031)
Figure 27. North America Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue Market Share by Country (2020-2031)
Figure 28. United States Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. Canada Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. Europe Anti-Inflammatory Analgesic and Antipyretic Drugs Sales Market Share by Country (2020-2031)
Figure 31. Europe Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue Market Share by Country (2020-2031)
Figure 32. Germany Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. France Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. U.K. Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. Italy Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. Russia Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. Asia Pacific Anti-Inflammatory Analgesic and Antipyretic Drugs Sales Market Share by Region (2020-2031)
Figure 38. Asia Pacific Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue Market Share by Region (2020-2031)
Figure 39. China Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Japan Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. South Korea Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. India Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Australia Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. China Taiwan Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Indonesia Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Thailand Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Malaysia Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Latin America Anti-Inflammatory Analgesic and Antipyretic Drugs Sales Market Share by Country (2020-2031)
Figure 49. Latin America Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue Market Share by Country (2020-2031)
Figure 50. Mexico Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. Brazil Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. Argentina Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. Middle East and Africa Anti-Inflammatory Analgesic and Antipyretic Drugs Sales Market Share by Country (2020-2031)
Figure 54. Middle East and Africa Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue Market Share by Country (2020-2031)
Figure 55. Turkey Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 56. Saudi Arabia Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 57. UAE Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 58. Global Sales Market Share of Anti-Inflammatory Analgesic and Antipyretic Drugs by Type (2020-2031)
Figure 59. Global Revenue Market Share of Anti-Inflammatory Analgesic and Antipyretic Drugs by Type (2020-2031)
Figure 60. Global Anti-Inflammatory Analgesic and Antipyretic Drugs Price (US$/Ton) by Type (2020-2031)
Figure 61. Global Sales Market Share of Anti-Inflammatory Analgesic and Antipyretic Drugs by Application (2020-2031)
Figure 62. Global Revenue Market Share of Anti-Inflammatory Analgesic and Antipyretic Drugs by Application (2020-2031)
Figure 63. Global Anti-Inflammatory Analgesic and Antipyretic Drugs Price (US$/Ton) by Application (2020-2031)
Figure 64. Anti-Inflammatory Analgesic and Antipyretic Drugs Value Chain
Figure 65. Channels of Distribution (Direct Vs Distribution)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
Table 1. Global Anti-Inflammatory Analgesic and Antipyretic Drugs Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Anti-Inflammatory Analgesic and Antipyretic Drugs Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Anti-Inflammatory Analgesic and Antipyretic Drugs Market Competitive Situation by Manufacturers in 2024
Table 4. Global Anti-Inflammatory Analgesic and Antipyretic Drugs Sales (Tons) of Key Manufacturers (2020-2025)
Table 5. Global Anti-Inflammatory Analgesic and Antipyretic Drugs Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Anti-Inflammatory Analgesic and Antipyretic Drugs Average Price (US$/Ton) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Anti-Inflammatory Analgesic and Antipyretic Drugs, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Anti-Inflammatory Analgesic and Antipyretic Drugs, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Anti-Inflammatory Analgesic and Antipyretic Drugs, Product Type & Application
Table 12. Global Key Manufacturers of Anti-Inflammatory Analgesic and Antipyretic Drugs, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Anti-Inflammatory Analgesic and Antipyretic Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-Inflammatory Analgesic and Antipyretic Drugs as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Anti-Inflammatory Analgesic and Antipyretic Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Anti-Inflammatory Analgesic and Antipyretic Drugs Sales by Region (2020-2025) & (Tons)
Table 18. Global Anti-Inflammatory Analgesic and Antipyretic Drugs Sales Market Share by Region (2020-2025)
Table 19. Global Anti-Inflammatory Analgesic and Antipyretic Drugs Sales by Region (2026-2031) & (Tons)
Table 20. Global Anti-Inflammatory Analgesic and Antipyretic Drugs Sales Market Share by Region (2026-2031)
Table 21. Global Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue Market Share by Region (2020-2025)
Table 23. Global Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue Market Share by Region (2026-2031)
Table 25. North America Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Anti-Inflammatory Analgesic and Antipyretic Drugs Sales by Country (2020-2025) & (Tons)
Table 27. North America Anti-Inflammatory Analgesic and Antipyretic Drugs Sales by Country (2026-2031) & (Tons)
Table 28. North America Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Anti-Inflammatory Analgesic and Antipyretic Drugs Sales by Country (2020-2025) & (Tons)
Table 32. Europe Anti-Inflammatory Analgesic and Antipyretic Drugs Sales by Country (2026-2031) & (Tons)
Table 33. Europe Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Anti-Inflammatory Analgesic and Antipyretic Drugs Sales by Region (2020-2025) & (Tons)
Table 37. Asia Pacific Anti-Inflammatory Analgesic and Antipyretic Drugs Sales by Region (2026-2031) & (Tons)
Table 38. Asia Pacific Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Anti-Inflammatory Analgesic and Antipyretic Drugs Sales by Country (2020-2025) & (Tons)
Table 42. Latin America Anti-Inflammatory Analgesic and Antipyretic Drugs Sales by Country (2026-2031) & (Tons)
Table 43. Latin America Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Anti-Inflammatory Analgesic and Antipyretic Drugs Sales by Country (2020-2025) & (Tons)
Table 47. Middle East and Africa Anti-Inflammatory Analgesic and Antipyretic Drugs Sales by Country (2026-2031) & (Tons)
Table 48. Middle East and Africa Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Anti-Inflammatory Analgesic and Antipyretic Drugs Sales (Tons) by Type (2020-2025)
Table 51. Global Anti-Inflammatory Analgesic and Antipyretic Drugs Sales (Tons) by Type (2026-2031)
Table 52. Global Anti-Inflammatory Analgesic and Antipyretic Drugs Sales Market Share by Type (2020-2025)
Table 53. Global Anti-Inflammatory Analgesic and Antipyretic Drugs Sales Market Share by Type (2026-2031)
Table 54. Global Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue Market Share by Type (2020-2025)
Table 57. Global Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue Market Share by Type (2026-2031)
Table 58. Global Anti-Inflammatory Analgesic and Antipyretic Drugs Price (US$/Ton) by Type (2020-2025)
Table 59. Global Anti-Inflammatory Analgesic and Antipyretic Drugs Price (US$/Ton) by Type (2026-2031)
Table 60. Global Anti-Inflammatory Analgesic and Antipyretic Drugs Sales (Tons) by Application (2020-2025)
Table 61. Global Anti-Inflammatory Analgesic and Antipyretic Drugs Sales (Tons) by Application (2026-2031)
Table 62. Global Anti-Inflammatory Analgesic and Antipyretic Drugs Sales Market Share by Application (2020-2025)
Table 63. Global Anti-Inflammatory Analgesic and Antipyretic Drugs Sales Market Share by Application (2026-2031)
Table 64. Global Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue Market Share by Application (2020-2025)
Table 67. Global Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue Market Share by Application (2026-2031)
Table 68. Global Anti-Inflammatory Analgesic and Antipyretic Drugs Price (US$/Ton) by Application (2020-2025)
Table 69. Global Anti-Inflammatory Analgesic and Antipyretic Drugs Price (US$/Ton) by Application (2026-2031)
Table 70. Mallinckrodt Pharmaceuticals Company Information
Table 71. Mallinckrodt Pharmaceuticals Description and Business Overview
Table 72. Mallinckrodt Pharmaceuticals Anti-Inflammatory Analgesic and Antipyretic Drugs Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 73. Mallinckrodt Pharmaceuticals Anti-Inflammatory Analgesic and Antipyretic Drugs Product
Table 74. Mallinckrodt Pharmaceuticals Recent Developments/Updates
Table 75. IOL Company Information
Table 76. IOL Description and Business Overview
Table 77. IOL Anti-Inflammatory Analgesic and Antipyretic Drugs Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 78. IOL Anti-Inflammatory Analgesic and Antipyretic Drugs Product
Table 79. IOL Recent Developments/Updates
Table 80. Anqiu Lu'an Pharmaceutical Company Information
Table 81. Anqiu Lu'an Pharmaceutical Description and Business Overview
Table 82. Anqiu Lu'an Pharmaceutical Anti-Inflammatory Analgesic and Antipyretic Drugs Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 83. Anqiu Lu'an Pharmaceutical Anti-Inflammatory Analgesic and Antipyretic Drugs Product
Table 84. Anqiu Lu'an Pharmaceutical Recent Developments/Updates
Table 85. Novacyl Company Information
Table 86. Novacyl Description and Business Overview
Table 87. Novacyl Anti-Inflammatory Analgesic and Antipyretic Drugs Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 88. Novacyl Anti-Inflammatory Analgesic and Antipyretic Drugs Product
Table 89. Novacyl Recent Developments/Updates
Table 90. BASF Company Information
Table 91. BASF Description and Business Overview
Table 92. BASF Anti-Inflammatory Analgesic and Antipyretic Drugs Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 93. BASF Anti-Inflammatory Analgesic and Antipyretic Drugs Product
Table 94. BASF Recent Developments/Updates
Table 95. Anhui BBCA Pharmaceuticals Company Information
Table 96. Anhui BBCA Pharmaceuticals Description and Business Overview
Table 97. Anhui BBCA Pharmaceuticals Anti-Inflammatory Analgesic and Antipyretic Drugs Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 98. Anhui BBCA Pharmaceuticals Anti-Inflammatory Analgesic and Antipyretic Drugs Product
Table 99. Anhui BBCA Pharmaceuticals Recent Developments/Updates
Table 100. Hubei Biocause Company Information
Table 101. Hubei Biocause Description and Business Overview
Table 102. Hubei Biocause Anti-Inflammatory Analgesic and Antipyretic Drugs Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 103. Hubei Biocause Anti-Inflammatory Analgesic and Antipyretic Drugs Product
Table 104. Hubei Biocause Recent Developments/Updates
Table 105. Xinhua Pharm Company Information
Table 106. Xinhua Pharm Description and Business Overview
Table 107. Xinhua Pharm Anti-Inflammatory Analgesic and Antipyretic Drugs Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 108. Xinhua Pharm Anti-Inflammatory Analgesic and Antipyretic Drugs Product
Table 109. Xinhua Pharm Recent Developments/Updates
Table 110. Granules India Limited Company Information
Table 111. Granules India Limited Description and Business Overview
Table 112. Granules India Limited Anti-Inflammatory Analgesic and Antipyretic Drugs Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 113. Granules India Limited Anti-Inflammatory Analgesic and Antipyretic Drugs Product
Table 114. Granules India Limited Recent Developments/Updates
Table 115. Huagang Pharm Company Information
Table 116. Huagang Pharm Description and Business Overview
Table 117. Huagang Pharm Anti-Inflammatory Analgesic and Antipyretic Drugs Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 118. Huagang Pharm Anti-Inflammatory Analgesic and Antipyretic Drugs Product
Table 119. Huagang Pharm Recent Developments/Updates
Table 120. Hebei Jiheng Pharmaceutical Company Information
Table 121. Hebei Jiheng Pharmaceutical Description and Business Overview
Table 122. Hebei Jiheng Pharmaceutical Anti-Inflammatory Analgesic and Antipyretic Drugs Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 123. Hebei Jiheng Pharmaceutical Anti-Inflammatory Analgesic and Antipyretic Drugs Product
Table 124. Hebei Jiheng Pharmaceutical Recent Developments/Updates
Table 125. Zhejiang Kangle Pharmaceutical Company Information
Table 126. Zhejiang Kangle Pharmaceutical Description and Business Overview
Table 127. Zhejiang Kangle Pharmaceutical Anti-Inflammatory Analgesic and Antipyretic Drugs Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 128. Zhejiang Kangle Pharmaceutical Anti-Inflammatory Analgesic and Antipyretic Drugs Product
Table 129. Zhejiang Kangle Pharmaceutical Recent Developments/Updates
Table 130. Hebei Jingye Medical Technology Company Information
Table 131. Hebei Jingye Medical Technology Description and Business Overview
Table 132. Hebei Jingye Medical Technology Anti-Inflammatory Analgesic and Antipyretic Drugs Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 133. Hebei Jingye Medical Technology Anti-Inflammatory Analgesic and Antipyretic Drugs Product
Table 134. Hebei Jingye Medical Technology Recent Developments/Updates
Table 135. MSPF Company Information
Table 136. MSPF Description and Business Overview
Table 137. MSPF Anti-Inflammatory Analgesic and Antipyretic Drugs Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 138. MSPF Anti-Inflammatory Analgesic and Antipyretic Drugs Product
Table 139. MSPF Recent Developments/Updates
Table 140. Lu'an Pharmaceutical Company Information
Table 141. Lu'an Pharmaceutical Description and Business Overview
Table 142. Lu'an Pharmaceutical Anti-Inflammatory Analgesic and Antipyretic Drugs Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 143. Lu'an Pharmaceutical Anti-Inflammatory Analgesic and Antipyretic Drugs Product
Table 144. Lu'an Pharmaceutical Recent Developments/Updates
Table 145. Mallinckrodt Company Information
Table 146. Mallinckrodt Description and Business Overview
Table 147. Mallinckrodt Anti-Inflammatory Analgesic and Antipyretic Drugs Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 148. Mallinckrodt Anti-Inflammatory Analgesic and Antipyretic Drugs Product
Table 149. Mallinckrodt Recent Developments/Updates
Table 150. Farmson Company Information
Table 151. Farmson Description and Business Overview
Table 152. Farmson Anti-Inflammatory Analgesic and Antipyretic Drugs Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 153. Farmson Anti-Inflammatory Analgesic and Antipyretic Drugs Product
Table 154. Farmson Recent Developments/Updates
Table 155. Anhui Fubore Company Information
Table 156. Anhui Fubore Description and Business Overview
Table 157. Anhui Fubore Anti-Inflammatory Analgesic and Antipyretic Drugs Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 158. Anhui Fubore Anti-Inflammatory Analgesic and Antipyretic Drugs Product
Table 159. Anhui Fubore Recent Developments/Updates
Table 160. SKPL Company Information
Table 161. SKPL Description and Business Overview
Table 162. SKPL Anti-Inflammatory Analgesic and Antipyretic Drugs Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 163. SKPL Anti-Inflammatory Analgesic and Antipyretic Drugs Product
Table 164. SKPL Recent Developments/Updates
Table 165. Atabay Company Information
Table 166. Atabay Description and Business Overview
Table 167. Atabay Anti-Inflammatory Analgesic and Antipyretic Drugs Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 168. Atabay Anti-Inflammatory Analgesic and Antipyretic Drugs Product
Table 169. Atabay Recent Developments/Updates
Table 170. Huzhou Konch Pharmaceutical Company Information
Table 171. Huzhou Konch Pharmaceutical Description and Business Overview
Table 172. Huzhou Konch Pharmaceutical Anti-Inflammatory Analgesic and Antipyretic Drugs Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 173. Huzhou Konch Pharmaceutical Anti-Inflammatory Analgesic and Antipyretic Drugs Product
Table 174. Huzhou Konch Pharmaceutical Recent Developments/Updates
Table 175. Anhui Topsun Company Information
Table 176. Anhui Topsun Description and Business Overview
Table 177. Anhui Topsun Anti-Inflammatory Analgesic and Antipyretic Drugs Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 178. Anhui Topsun Anti-Inflammatory Analgesic and Antipyretic Drugs Product
Table 179. Anhui Topsun Recent Developments/Updates
Table 180. SOLARA Company Information
Table 181. SOLARA Description and Business Overview
Table 182. SOLARA Anti-Inflammatory Analgesic and Antipyretic Drugs Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 183. SOLARA Anti-Inflammatory Analgesic and Antipyretic Drugs Product
Table 184. SOLARA Recent Developments/Updates
Table 185. SI Group Company Information
Table 186. SI Group Description and Business Overview
Table 187. SI Group Anti-Inflammatory Analgesic and Antipyretic Drugs Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 188. SI Group Anti-Inflammatory Analgesic and Antipyretic Drugs Product
Table 189. SI Group Recent Developments/Updates
Table 190. Key Raw Materials Lists
Table 191. Raw Materials Key Suppliers Lists
Table 192. Anti-Inflammatory Analgesic and Antipyretic Drugs Distributors List
Table 193. Anti-Inflammatory Analgesic and Antipyretic Drugs Customers List
Table 194. Anti-Inflammatory Analgesic and Antipyretic Drugs Market Trends
Table 195. Anti-Inflammatory Analgesic and Antipyretic Drugs Market Drivers
Table 196. Anti-Inflammatory Analgesic and Antipyretic Drugs Market Challenges
Table 197. Anti-Inflammatory Analgesic and Antipyretic Drugs Market Restraints
Table 198. Research Programs/Design for This Report
Table 199. Key Data Information from Secondary Sources
Table 200. Key Data Information from Primary Sources
Table 201. Authors List of This Report
List of Figures
Figure 1. Product Picture of Anti-Inflammatory Analgesic and Antipyretic Drugs
Figure 2. Global Anti-Inflammatory Analgesic and Antipyretic Drugs Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Anti-Inflammatory Analgesic and Antipyretic Drugs Market Share by Type: 2024 & 2031
Figure 4. Paracetamol Product Picture
Figure 5. Aspirin Product Picture
Figure 6. Ibuprofen Product Picture
Figure 7. Naproxen Product Picture
Figure 8. Diclofenac Product Picture
Figure 9. Oxaprozin Product Picture
Figure 10. Dexibuprofen Product Picture
Figure 11. Others Product Picture
Figure 12. Global Anti-Inflammatory Analgesic and Antipyretic Drugs Market Value by Application (2020-2031) & (US$ Million)
Figure 13. Global Anti-Inflammatory Analgesic and Antipyretic Drugs Market Share by Application: 2024 & 2031
Figure 14. Adults
Figure 15. Children
Figure 16. Global Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 17. Global Anti-Inflammatory Analgesic and Antipyretic Drugs Market Size (2020-2031) & (US$ Million)
Figure 18. Global Anti-Inflammatory Analgesic and Antipyretic Drugs Sales (2020-2031) & (Tons)
Figure 19. Global Anti-Inflammatory Analgesic and Antipyretic Drugs Average Price (US$/Ton) & (2020-2031)
Figure 20. Anti-Inflammatory Analgesic and Antipyretic Drugs Report Years Considered
Figure 21. Anti-Inflammatory Analgesic and Antipyretic Drugs Sales Share by Manufacturers in 2024
Figure 22. Global Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue Share by Manufacturers in 2024
Figure 23. Global 5 and 10 Largest Anti-Inflammatory Analgesic and Antipyretic Drugs Players: Market Share by Revenue in Anti-Inflammatory Analgesic and Antipyretic Drugs in 2024
Figure 24. Anti-Inflammatory Analgesic and Antipyretic Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 25. Global Anti-Inflammatory Analgesic and Antipyretic Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 26. North America Anti-Inflammatory Analgesic and Antipyretic Drugs Sales Market Share by Country (2020-2031)
Figure 27. North America Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue Market Share by Country (2020-2031)
Figure 28. United States Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. Canada Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. Europe Anti-Inflammatory Analgesic and Antipyretic Drugs Sales Market Share by Country (2020-2031)
Figure 31. Europe Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue Market Share by Country (2020-2031)
Figure 32. Germany Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. France Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. U.K. Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. Italy Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. Russia Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. Asia Pacific Anti-Inflammatory Analgesic and Antipyretic Drugs Sales Market Share by Region (2020-2031)
Figure 38. Asia Pacific Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue Market Share by Region (2020-2031)
Figure 39. China Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Japan Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. South Korea Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. India Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Australia Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. China Taiwan Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Indonesia Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Thailand Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Malaysia Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Latin America Anti-Inflammatory Analgesic and Antipyretic Drugs Sales Market Share by Country (2020-2031)
Figure 49. Latin America Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue Market Share by Country (2020-2031)
Figure 50. Mexico Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. Brazil Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. Argentina Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. Middle East and Africa Anti-Inflammatory Analgesic and Antipyretic Drugs Sales Market Share by Country (2020-2031)
Figure 54. Middle East and Africa Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue Market Share by Country (2020-2031)
Figure 55. Turkey Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 56. Saudi Arabia Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 57. UAE Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 58. Global Sales Market Share of Anti-Inflammatory Analgesic and Antipyretic Drugs by Type (2020-2031)
Figure 59. Global Revenue Market Share of Anti-Inflammatory Analgesic and Antipyretic Drugs by Type (2020-2031)
Figure 60. Global Anti-Inflammatory Analgesic and Antipyretic Drugs Price (US$/Ton) by Type (2020-2031)
Figure 61. Global Sales Market Share of Anti-Inflammatory Analgesic and Antipyretic Drugs by Application (2020-2031)
Figure 62. Global Revenue Market Share of Anti-Inflammatory Analgesic and Antipyretic Drugs by Application (2020-2031)
Figure 63. Global Anti-Inflammatory Analgesic and Antipyretic Drugs Price (US$/Ton) by Application (2020-2031)
Figure 64. Anti-Inflammatory Analgesic and Antipyretic Drugs Value Chain
Figure 65. Channels of Distribution (Direct Vs Distribution)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Shielded Isolator Market Research Report 2025
Jan 25, 25
Global Compressor Nebulizers Market Research Report 2025
Jan 25, 25
Global Electric Mining Truck Market Research Report 2025
Jan 25, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232